← All stocks

Fulgent Genetics, Inc.

FLGT Net selling

CIK 0001674930 #3026 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$117.13K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$117.13K

4 of 4 sales

Net

−$117.13K

−$117.13K against sales at will

By person

7 insiders · 4 transactions

21.7×

Ming Hsieh holds 21.7 times base salary in stock. $21.79M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Ming Hsieh last reported holding, valued at $19.66, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Xie Jian

President and COO

—

$65.56K (2)

−$65.56K

580,740

2.11%

$11.42M

+6.3%

Gao Hanlin

Chief Scientific Officer

—

$51.58K (2)

−$51.58K

986,117

3.58%

$19.38M

+6.8%

Hsieh Ming

Chief Executive Officer

—

1,108,768

4.03%

$21.79M

+19.2%

Kim Paul

CFO and Treasurer

—

356,543

1.30%

$7.01M

+70.2%

Dong Linda

Director

—

38,758

0.1409%

$761.84K

+107.7%

GROVES REGINA E

Director

—

28,099

0.1021%

$552.33K

+251.2%

Nohaile Michael

Director

—

24,578

0.0893%

$483.11K

+69.2%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Xie Jian

2 Sep 2026

President and COO

Sell

2,127

$19.66

$41.81K

Gao Hanlin

2 Sep 2026

Chief Scientific Officer

Sell

1,673

$19.66

$32.89K

Gao Hanlin

27 Aug 2026

Chief Scientific Officer

Sell

939

$19.91

$18.69K

Xie Jian

27 Aug 2026

President and COO

Sell

1,193

$19.91

$23.75K

Show all 4 transactions →

What was left out

Form 4 filings counted 8

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 4

Transactions with no price 0

Shares from compensation/vesting 10,596

History held since 4 Oct 2016